Latest News and Press Releases

Autolus announces its operational and financial results for the first quarter ended March 31, 2025.

Autolus presented updates on its development pipeline and plans for expansion in autoimmune diseases at an R&D investor event.

Autolus will report Q1 2025 financial results on May 8, 2025.

Autolus will present in a fireside chat at the Needham Healthcare Conference on Wednesday, April 9, 2025.

Autolus will host an R&D investor event on Wednesday, April 23, 2025 at 8:30am EDT.

Autolus will report Q4 and FY 2024 financial results and operational updates on March 20, 2025.

Autolus will participate in two upcoming investor conferences: Jefferies Biotech on the Beach and Leerink Global Biopharma Conference.

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024

High overall response rate: 76.6% of patients in the pivotal cohort achieved CR/Cri following treatment with obe-cel with a median follow-up of 20.3 monthsLow incidence of immune-related toxicity:...

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates